These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
145 related items for PubMed ID: 9929501
1. Developmental changes in the catalytic activity and expression of CYP2D isoforms in the rat liver. Chow T, Imaoka S, Hiroi T, Funae Y. Drug Metab Dispos; 1999 Feb; 27(2):188-92. PubMed ID: 9929501 [Abstract] [Full Text] [Related]
2. Expression of four rat CYP2D isoforms in Saccharomyces cerevisiae and their catalytic specificity. Wan J, Imaoka S, Chow T, Hiroi T, Yabusaki Y, Funae Y. Arch Biochem Biophys; 1997 Dec 15; 348(2):383-90. PubMed ID: 9434752 [Abstract] [Full Text] [Related]
3. The ability of cytochrome P450 2D isoforms to synthesize dopamine in the brain: An in vitro study. Bromek E, Haduch A, Daniel WA. Eur J Pharmacol; 2010 Jan 25; 626(2-3):171-8. PubMed ID: 19818757 [Abstract] [Full Text] [Related]
4. Catalytic specificity of CYP2D isoforms in rat and human. Hiroi T, Chow T, Imaoka S, Funae Y. Drug Metab Dispos; 2002 Sep 25; 30(9):970-6. PubMed ID: 12167561 [Abstract] [Full Text] [Related]
5. The 1'-hydroxylation of Rac-bufuralol by rat brain microsomes. Coleman T, Spellman EF, Rostami-Hodjegan A, Lennard MS, Tucker GT. Drug Metab Dispos; 2000 Sep 25; 28(9):1094-9. PubMed ID: 10950855 [Abstract] [Full Text] [Related]
6. The molecular mechanisms of two common polymorphisms of drug oxidation--evidence for functional changes in cytochrome P-450 isozymes catalysing bufuralol and mephenytoin oxidation. Meyer UA, Gut J, Kronbach T, Skoda C, Meier UT, Catin T, Dayer P. Xenobiotica; 1986 May 25; 16(5):449-64. PubMed ID: 2874666 [Abstract] [Full Text] [Related]
7. Importance of CYP2D3 in polymorphism of diazepam p-hydroxylation in rats. Sakai N, Saito K, Kim HS, Kazusaka A, Ishizuka M, Funae Y, Fujita S. Drug Metab Dispos; 2005 Nov 25; 33(11):1657-60. PubMed ID: 16081673 [Abstract] [Full Text] [Related]
8. Purification and characterization of a dog cytochrome P450 isozyme belonging to the CYP2D subfamily and development of its antipeptide antibody. Nakamura A, Yamamoto Y, Tasaki T, Sugimoto C, Masuda M, Kazusaka A, Fujita S. Drug Metab Dispos; 1995 Nov 25; 23(11):1268-73. PubMed ID: 8591729 [Abstract] [Full Text] [Related]
9. (+)-bufuralol 1'-hydroxylation activity in human and rhesus monkey intestine and liver. Prueksaritanont T, Dwyer LM, Cribb AE. Biochem Pharmacol; 1995 Oct 26; 50(9):1521-5. PubMed ID: 7503805 [Abstract] [Full Text] [Related]
10. Regioselective contribution of the cytochrome P-450 2D subfamily to propranolol metabolism in rat liver microsomes. Masubuchi Y, Kagimoto N, Narimatsu S, Fujita S, Suzuki T. Drug Metab Dispos; 1993 Oct 26; 21(6):1012-6. PubMed ID: 7905378 [Abstract] [Full Text] [Related]
11. Cytochrome P4502D isozymes catalyze the 4-hydroxylation of methamphetamine enantiomers. Lin LY, Kumagai Y, Hiratsuka A, Narimatsu S, Suzuki T, Funae Y, Distefano EW, Cho AK. Drug Metab Dispos; 1995 Jun 26; 23(6):610-4. PubMed ID: 7587941 [Abstract] [Full Text] [Related]
12. Participation of cytochrome P450-2B and -2D isozymes in the demethylenation of methylenedioxymethamphetamine enantiomers by rats. Kumagai Y, Lin LY, Hiratsuka A, Narimatsu S, Suzuki T, Yamada H, Oguri K, Yoshimura H, Cho AK. Mol Pharmacol; 1994 Feb 26; 45(2):359-65. PubMed ID: 7906857 [Abstract] [Full Text] [Related]
13. Differential roles of cytochromes P450 2D1, 2C11, and 1A1/2 in the hydroxylation of bufuralol by rat liver microsomes. Mimura M, Yamazaki H, Sugahara C, Hiroi T, Funae Y, Shimada T. Biochem Pharmacol; 1994 Jun 01; 47(11):1957-63. PubMed ID: 7912070 [Abstract] [Full Text] [Related]
14. Dopamine formation from tyramine by CYP2D6. Hiroi T, Imaoka S, Funae Y. Biochem Biophys Res Commun; 1998 Aug 28; 249(3):838-43. PubMed ID: 9731223 [Abstract] [Full Text] [Related]
15. Relationship between oxidative metabolism of 2-acetylaminofluorene, debrisoquine, bufuralol, and aldrin in human liver microsomes. McManus ME, Boobis AR, Minchin RF, Schwartz DM, Murray S, Davies DS, Thorgeirsson SS. Cancer Res; 1984 Dec 28; 44(12 Pt 1):5692-7. PubMed ID: 6498831 [Abstract] [Full Text] [Related]
16. Different effects of desipramine on bufuralol 1''-hydroxylation by rat and human CYP2D enzymes. Isobe T, Hichiya H, Hanioka N, Yamamoto S, Shinoda S, Funae Y, Satoh T, Yamano S, Narimatsu S. Biol Pharm Bull; 2005 Apr 28; 28(4):634-40. PubMed ID: 15802801 [Abstract] [Full Text] [Related]
17. Tissue distributions of CYP2D1, 2D2, 2D3 and 2D4 mRNA in rats detected by RT-PCR. Hiroi T, Imaoka S, Chow T, Funae Y. Biochim Biophys Acta; 1998 May 08; 1380(3):305-12. PubMed ID: 9555068 [Abstract] [Full Text] [Related]
18. Inhibitory effect of rifampicin on the depressive action of interleukin-1 on cytochrome P-450-linked monooxygenase system. Kurokohchi K, Yoneyama H, Nishioka M, Ichikawa Y. Metabolism; 2001 Feb 08; 50(2):231-6. PubMed ID: 11229434 [Abstract] [Full Text] [Related]
19. The effect of psychotropic drugs on cytochrome P450 2D (CYP2D) in rat brain. Haduch A, Bromek E, Daniel WA. Eur J Pharmacol; 2011 Jan 25; 651(1-3):51-8. PubMed ID: 21115002 [Abstract] [Full Text] [Related]
20. Characterization of cytochrome P450-mediated drug metabolism in cats. Shah SS, Sanda S, Regmi NL, Sasaki K, Shimoda M. J Vet Pharmacol Ther; 2007 Oct 25; 30(5):422-8. PubMed ID: 17803734 [Abstract] [Full Text] [Related] Page: [Next] [New Search]